Clinical Trial Update: Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex

View source ↗

Summary

A completed clinical trial from Beijing Children's Hospital investigated predicting epileptogenic tubers in patients with tuberous sclerosis complex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex

Snippet

Sponsor: Beijing Children's Hospital | Conditions: Tuberous Sclerosis Complex | Status: COMPLETED